Surmodics, Inc. (SRDX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.07 |
| Open | 25.47 |
| Bid | 26.07 x 100 |
| Ask | 26.34 x 100 |
| Day's range | 25.22 - 26.22 |
| 52-week range | 16.79 - 39.41 |
| Volume | |
| Avg. volume | 64,722 |
| Market cap | 372.556M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 67.10 |
| EPS (TTM) | 0.39 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 59.00 |
Business WireSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
EDEN PRAIRIE, Minn., April 19, 2024--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1.
ZacksResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksWill SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.